COLL
Price:
$34.64
Market Cap:
$1.12B
Collegium Pharmaceutical, Inc. (COLL) is a specialized pharmaceutical firm dedicated to the development and marketing of medications for pain management. Its diverse product lineup features significant therapies aimed at addressing various pain conditions. A prominent offering is Xtampza ER, an extended-release, oral formulation of oxycodone, specifically engineered with properties to deter abuse. This particular drug is prescribed for patients experiencing severe, persistent pain that necessitates daily, continuous, long-term opioid therapy. The company's portfolio also encompasses Nucynta ER and Nucynta IR, which are extended-release and immediate-release versions of tapentadol, respective...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2015-05-07
Stock Exchange
NASDAQ
Ticker
COLL
According to Collegium Pharmaceutical, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.71. This represents a change of 17.76% compared to the average of 1.46 of the last 4 quarters.
The mean historical Current Ratio of Collegium Pharmaceutical, Inc. over the last ten years is 2.06. The current 1.71 Current Ratio has changed 8.21% with respect to the historical average. Over the past ten years (40 quarters), COLL's Current Ratio was at its highest in in the December 2016 quarter at 6.92. The Current Ratio was at its lowest in in the September 2018 quarter at 0.78.
Average
2.06
Median
1.22
Minimum
0.95
Maximum
6.92
Discovering the peaks and valleys of Collegium Pharmaceutical, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 66.01%
Maximum Annual Current Ratio = 6.92
Minimum Annual Increase = -70.12%
Minimum Annual Current Ratio = 0.95
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 1.57 | 66.01% |
| 2024 | 0.95 | -19.38% |
| 2023 | 1.17 | 21.24% |
| 2022 | 0.97 | -14.21% |
| 2021 | 1.13 | -2.74% |
| 2020 | 1.16 | -8.43% |
| 2019 | 1.27 | 0.05% |
| 2018 | 1.27 | -70.12% |
| 2017 | 4.24 | -38.70% |
| 2016 | 6.92 | -58.85% |
The current Current Ratio of Collegium Pharmaceutical, Inc. (COLL) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
1.23
5-year avg
1.16
10-year avg
2.06
Collegium Pharmaceutical, Inc.’s Current Ratio is less than Amphastar Pharmaceuticals, Inc. (3.85), less than Dynavax Technologies Corporation (7.62), less than Cronos Group Inc. (21.87), greater than GoodRx Holdings, Inc. (1.47), less than Innoviva, Inc. (21.13), less than Pacira BioSciences, Inc. (4.73), less than MiMedx Group, Inc. (5.39), less than Pulse Biosciences, Inc. (7.26), less than Atai Beckley Inc. (10.02), less than Nektar Therapeutics (10.21),
| Company | Current Ratio | Market cap |
|---|---|---|
| 3.85 | $885.83M | |
| 7.62 | $1.82B | |
| 21.87 | $1.00B | |
| 1.47 | $918.57M | |
| 21.13 | $1.68B | |
| 4.73 | $904.31M | |
| 5.39 | $536.20M | |
| 7.26 | $1.69B | |
| 10.02 | $1.44B | |
| 10.21 | $1.16B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Collegium Pharmaceutical, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Collegium Pharmaceutical, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Collegium Pharmaceutical, Inc.'s Current Ratio?
How is the Current Ratio calculated for Collegium Pharmaceutical, Inc. (COLL)?
What is the highest Current Ratio for Collegium Pharmaceutical, Inc. (COLL)?
What is the 3-year average Current Ratio for Collegium Pharmaceutical, Inc. (COLL)?
What is the 5-year average Current Ratio for Collegium Pharmaceutical, Inc. (COLL)?
How does the current Current Ratio for Collegium Pharmaceutical, Inc. (COLL) compare to its historical average?